CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 48  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.1310
LYS 10.0360
GLU 20.0296
LEU 30.0372
ARG 40.0436
CYS 50.0142
GLN 60.0198
CYS 70.0433
ILE 80.0895
LYS 90.0447
THR 100.0184
TYR 110.0139
SER 120.0394
LYS 130.0493
PRO 140.0491
PHE 150.0295
HIS 160.0185
PRO 170.0154
LYS 180.0333
PHE 190.0219
ILE 200.0096
LYS 210.0130
GLU 220.0145
LEU 230.0040
ARG 240.0091
VAL 250.0130
ILE 260.0087
GLU 270.0090
SER 280.0127
GLY 290.0328
PRO 300.0168
HIS 310.0200
CYS 320.0173
ALA 330.0408
ASN 340.0093
THR 350.0099
GLU 360.0046
ILE 370.0080
ILE 380.0069
VAL 390.0031
LYS 400.0088
LEU 410.0083
SER 420.0100
ASP 430.0377
GLY 440.0156
ARG 450.0269
GLU 460.0098
LEU 470.0132
CYS 480.0217
LEU 490.0052
ASP 500.0091
PRO 510.0119
LYS 520.0147
GLU 530.0163
ASN 540.0062
TRP 550.0222
VAL 560.0112
GLN 570.0060
ARG 580.0107
VAL 590.0094
VAL 600.0079
GLU 610.0180
LYS 620.0113
PHE 630.0163
LEU 640.0308
LYS 650.0270
ARG 660.0292
ALA 670.0365
GLU 680.0398
ASN 690.1310

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.